A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
Aki
Z
Z
Kotiloğlu
G
G
Ozyilkan
O
O
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy*; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D019934:International Normalized Ratio; D011517:Prothrombin Time; D013274:Stomach Neoplasms / Q000097:blood / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
D000925:Anticoagulants; D000964:Antimetabolites, Antineoplastic; D014859:Warfarin; D005472:Fluorouracil